Neostigmine and Dexamethasone in Adductor Canal Block
A Comparative Study Between Neostigmine and Dexamethasone as an Adjuvant to Bupivacaine in Adductor Canal Block After Knee Arthroscopy Surgery
Sponsor: Cairo University
This NA trial investigates Pain, Postoperative and is currently completed. Cairo University leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jul 2022 — Sep 2022 [monthly]
Recruiting NA
-
Sep 2021 — Jul 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Oct 2020 — Dec 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cairo University
For direct contact, visit the study record on ClinicalTrials.gov .